Familiar AI Is Just the Lobby. The Real Work Happens Further In.

Life sciences sales and marketing professionals are cautiously optimistic about AI. But across the industry, even those who have started are largely still standing in the lobby.

Copying and pasting into your favorite large language model is not a strategy, and according to Wharton researchers Shaw and Nave, it can actively lead to cognitive surrender. Using the same three prompts on repeat is also not a solution.Your buyers are complex, your products are technical, and the commercial challenges you face - multi-stakeholder decisions, regulatory constraints, messaging precision - deserve better than surface-level outputs from a general-purpose tool.

You have felt it in the gap between what AI promised and what it actually delivered on a Tuesday afternoon when you needed a compelling value proposition for a procurement committee, and got something that sounded like it was written for everyone and no one.

That gap is closeable. And it closes faster than you think.

This SAMPS webinar panel is a practitioner-led conversation about what AI can actually do when you go further in - across messaging, workflow automation, sales enablement, synthetic buyer research, and word-of-mouth strategy. Our panelists bring perspectives from life sciences commercial strategy, marketing execution, frontline sales, and beyond the industry.

They are not theorists. They have already moved past the lobby, and they are bringing the map.

What You'll Learn

•     Which AI tools and workflows are delivering real results for life sciences sales and marketing teams beyond the platforms you already know

•     How to move from generic outputs to precise, audience-specific messaging that resonates with technical buyers and procurement committees

•     The mindset shift that separates commercial teams who are dabbling from those who are genuinely pulling ahead

By the end of this session, you will leave with a shortlist of tools and workflows your team can test this quarter, a clearer picture of where the real leverage sits in your commercial process, and the confidence to move from experimentation to execution.

Panelists:  Ann Brine (Promega), Matt Wilkinson (Strivenn), Nick Claire (Succession), Sarah Neely (SignalSwell)

Date:  June 10

‍